Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Neoplasms × Exercise Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Motor Activity 5 Fatigue 3 Depression 3 Breast Cancer Lymphedema 2 Anxiety Disorders 2 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain 1 Osteosclerosis 1 Osteoarthritis, Knee 1 Neurotoxicity Syndromes 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Lymphedema 1 Lung Neoplasms 1 Kinesiophobia 1 Head and Neck Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Body Weight Changes 1 Arthritis 1 Accessory Nerve Injuries 1

Interventions

Ibandronic Acid 5 pembrolizumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Injections 2 Denosumab 2 selinexor 1 ridaforolimus 1 radium Ra 223 dichloride 1 pegfilgrastim 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 endostar protein 1 cc-486 1 angiotensin I (1-7) 1 Zoledronic Acid 1 Vincristine 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Transcranial Direct Current Stimulation 1 Trabectedin 1 Tomography, Spiral Computed 1 TES 1 Surveys and Questionnaires 1 Standard of Care 1 Radiomics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04963517 2024-12-06

proGAIT

Universität Duisburg-Essen

Phase 2/3 Completed

Bone Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡